COMBINED TISSUE PLASMINOGEN ACTIVATOR AND AN NK1 TACHYKININ RECEPTOR ANTAGONIST: AN EFFECTIVE TREATMENT FOR REPERFUSION INJURY FOLLOWING ACUTE ISCHEMIC STROKE IN RATSTURNER, R. J; VINK, R.Neuroscience. 2012, Vol 220, pp 1-10, issn 0306-4522, 10 p.Article

The tachykinin NK₁ receptor. Part II: distribution and pathophysiological rolesQUARTARA, L; MAGGI, C. A.Neuropeptides (Edinburgh). 1998, Vol 32, Num 1, pp 1-49, issn 0143-4179Article

The role of the amino-terminal domain of tachykinins in neurokinin-1 receptor signaling and desensitizationVIGNA, Steven R.Neuropeptides (Edinburgh). 2003, Vol 37, Num 1, pp 30-35, issn 0143-4179, 6 p.Article

Rolapitant for the Prevention of Postoperative Nausea and Vomiting: A Prospective, Double-Blinded, Placebo-Controlled Randomized TrialGAN, Tong J; JIEZHUN GU; CREED, Mary R et al.Anesthesia and analgesia. 2011, Vol 112, Num 4, pp 804-812, issn 0003-2999, 9 p.Article

Substance P (NK₁) receptor antagonists-analgesics or not?BOYCE, S; HILL, R. G.Handbook of experimental pharmacology. 2004, Vol 164, pp 441-457, issn 0171-2004, 17 p.Article

Inflammation-induced up-regulation of neurokinin 1 receptors in rat glabrous skinCARLTON, Susan M; COGGESHALL, Richard E.Neuroscience letters. 2002, Vol 326, Num 1, pp 29-32, issn 0304-3940Article

Tachykinin NK₁ receptor antagonistsPATACCHINI, R; MAGGI, C. A.Handbook of experimental pharmacology. 2004, Vol 164, pp 173-218, issn 0171-2004, 46 p.Article

Generation of a transgenic model to address regulation and function of the human neurokinin 1 receptor (NK1R)VASILIOU, A. S; MACKENZIE, A; MORRIS, R et al.Neuropeptides (Edinburgh). 2007, Vol 41, Num 4, pp 195-205, issn 0143-4179, 11 p.Article

Stress-induced increase of cortical dopamine metabolism: attenuation by a tachykinin NK₁ receptor antagonistHUTSON, Peter H; PATEL, Shil; JAY, Mark T et al.European journal of pharmacology. 2004, Vol 484, Num 1, pp 57-64, issn 0014-2999, 8 p.Article

Pharmacology of MEN 11467 : a potent new selective and orally-effective peptidomimetic tachykinin NK₁ receptor antagonistCIRILLO, R; ASTOLFI, M; MAGGI, C. A et al.Neuropeptides (Edinburgh). 2001, Vol 35, Num 3-4, pp 137-147, issn 0143-4179Article

Differences in the expression of neurokinin receptor in neural and bone marrow mesenchymal cells: implications for neuronal expansion from bone marrow cellsBANDARI, P. S; QIAN, J; YEHIA, G et al.Neuropeptides (Edinburgh). 2002, Vol 36, Num 1, pp 13-21, issn 0143-4179Article

NMR spectroscopy and surface tension measurements applied to the study of self-association of casopitant mesylate, a novel NK1 antagonistPROVERA, Stefano; BEATO, Stefania; CIMAROSTI, Zadeo et al.Journal of pharmaceutical and biomedical analysis. 2011, Vol 54, Num 1, pp 48-52, issn 0731-7085, 5 p.Article

Partial involvement of NMDA receptors and glial cells in the nociceptive behaviors induced by intrathecally administered histamineMIZOGUCHI, Hirokazu; KOMATSU, Takaaki; SAKURADA, Shinobu et al.Neuroscience letters. 2011, Vol 495, Num 2, pp 83-87, issn 0304-3940, 5 p.Article

Actualités sur les nausées et les vomissements en 2010 : Mises au point du 46^e congrès de Chicago en oncologie clinique (4-8 juin) et de la MASCC Multinational Assciation of Supportive Care in Cancer (Vancouver, 24-26 juin)SCOTTE, Florian.La Lettre du cancérologue (Boulogne). 2010, Vol 19, issn 1165-113X, 7 p., SUP2Serial Issue

Electrical stimulation of the mucosa evokes slow EPSPs mediated by NK1 tachykinin receptors and by P2Y₁ purinoceptors in different myenteric neuronsGWYNNE, Rachel M; BORNSTEIN, Joel C.American journal of physiology. Gastrointestinal and liver physiology. 2009, Vol 60, Num 1, issn 0193-1857, G179-G186Article

Neurokinin-1 receptor antagonists in the prevention of postoperative nausea and vomitingDIEMUNSCH, P; JOSHI, G. P; BRICHANT, J.-F et al.British journal of anaesthesia. 2009, Vol 103, Num 1, pp 7-13, issn 0007-0912, 7 p.Article

Unilateral intra-perilymphatic infusion of substance P enhances ipsilateral vestibulo-ocular reflex gains in the sinusoidal rotation testORITA, Hiroshi; SHIMOGORI, Hiroaki; YAMASHITA, Hiroshi et al.Neuroscience letters. 2009, Vol 449, Num 3, pp 207-210, issn 0304-3940, 4 p.Article

Anxiogenic effects of activation of NK-1 receptors of the dorsal periaqueductal gray as assessed by the elevated plus-maze, ultrasound vocalizations and tail-flick testsBASSI, Gabriel S; NOBRE, Manoel J; DE ARAUJO, Joao E et al.Neuropeptides (Edinburgh). 2007, Vol 41, Num 6, pp 365-374, issn 0143-4179, 10 p.Article

An HPLC chromatographic reactor approach for investigating the hydrolytic stability of a pharmaceutical compoundSKRDLA, Peter J; ABRAHIM, Ahmed; YAN WU et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 3, pp 883-890, issn 0731-7085, 8 p.Article

Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patientsNYGREN, Peter; HANDE, Kenneth; GOTTESDIENER, Keith M et al.Cancer chemotherapy and pharmacology. 2005, Vol 55, Num 6, pp 609-616, issn 0344-5704, 8 p.Article

Synthesis of a tetrahydropyran NK₁ receptor antagonist via asymmetric conjugate additionHUFFMAN, Mark A; SMITROVICH, Jacqueline H; ROSEN, Jonathan D et al.Journal of organic chemistry. 2005, Vol 70, Num 11, pp 4409-4413, issn 0022-3263, 5 p.Article

Activation of central neurokinin-1 receptors induces reinstatement of cocaine-seeking behaviorPLACENZA, Franca M; VACCARINO, Franco J; FLETCHER, Paul J et al.Neuroscience letters. 2005, Vol 390, Num 1, pp 42-47, issn 0304-3940, 6 p.Article

The role of tachykinins and the tachykinin NK₁ receptor in nausea and emesisANDREWS, P. L. R; RUDD, J. A.Handbook of experimental pharmacology. 2004, Vol 164, pp 359-440, issn 0171-2004, 82 p.Article

Demonstration of the efficacy and safety of a novel Substance P (NK₁) receptor antagonist in major DepressionKRAMER, Mark S; WINOKUR, Andrew; APTER, Jeffrey T et al.Neuropsychopharmacology (New York, NY). 2004, Vol 29, Num 2, pp 385-392, issn 0893-133X, 8 p.Article

Tachykinin NK₃ and NK₁ receptor activation elicits secretion from porcine airway submucosal glandsPHILLIPS, Jonathan E; HEY, John A; CORBOZ, Michel R et al.British journal of pharmacology. 2003, Vol 138, Num 1, pp 254-260, issn 0007-1188, 7 p.Article